Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Over-activation of epidermal growth factor receptor (EGFR) is common in non-small cell lung carcinomas (NSCLC).
• Understanding the genetic alterations influencing EGFR expression is crucial for targeted therapies.

Purpose of the Study:

• To investigate the role of chromosome 7 multiplication in EGFR expression.
• To determine the combined influence of chromosome 7 multiplication and EGFR gene amplification on EGFR expression in NSCLC.

Main Methods:

• Utilized tissue microarray technology with 50 primary NSCLC samples.
• Performed immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) to assess EGFR expression, gene amplification, and chromosome 7 polysomy.

Main Results:

• EGFR expression was detected in 80% of cases, with over-expression in 57.5%.
• Gene amplification was found in 22% and chromosome 7 polysomy in 16% of cases.
• EGFR expression significantly correlated with both EGFR gene amplification (p=0.001) and chromosome 7 centromere numerical imbalances (p=0.004).

Conclusions:

• EGFR expression in NSCLC is associated with both gene amplification and increased copies of chromosome 7 centromeres.
• Chromosome 7 multiplication, whether through centromere amplification or polysomy, is a critical factor for selecting patients eligible for monoclonal antibody-targeted therapies.